These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31836524)

  • 1. Application of cytochrome P450 reactivity on the characterization of chemical compounds and its association with repeated-dose toxicity.
    Watanabe M; Sasaki T; Takeshita JI; Kushida M; Shimizu Y; Oki H; Kitsunai Y; Nakayama H; Saruhashi H; Ogura R; Shizu R; Hosaka T; Yoshinari K
    Toxicol Appl Pharmacol; 2020 Feb; 388():114854. PubMed ID: 31836524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
    Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
    Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
    Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
    Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K3 (menadione) redox cycling inhibits cytochrome P450-mediated metabolism and inhibits parathion intoxication.
    Jan YH; Richardson JR; Baker AA; Mishin V; Heck DE; Laskin DL; Laskin JD
    Toxicol Appl Pharmacol; 2015 Oct; 288(1):114-20. PubMed ID: 26212258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.
    Rendic SP; Peter Guengerich F
    Drug Metab Rev; 2018 Aug; 50(3):256-342. PubMed ID: 30717606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.
    Vignati L; Turlizzi E; Monaci S; Grossi P; Kanter Rd; Monshouwer M
    Toxicology; 2005 Dec; 216(2-3):154-67. PubMed ID: 16169652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
    Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
    Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible and time-dependent inhibition of the hepatic cytochrome P450 steroidal hydroxylases by the proestrogenic pesticide methoxychlor in rat and human.
    Li HC; Mani C; Kupfer D
    J Biochem Toxicol; 1993 Dec; 8(4):195-206. PubMed ID: 8114062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes.
    Weber GF; Waxman DJ
    Biochem Pharmacol; 1993 Apr; 45(8):1685-94. PubMed ID: 8484807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
    Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
    Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS.
    Otten JN; Hingorani GP; Hartley DP; Kragerud SD; Franklin RB
    Drug Metab Lett; 2011 Jan; 5(1):17-24. PubMed ID: 21198441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
    Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the amount of cytochrome P450s in rat hepatic microsomes with starvation.
    Imaoka S; Terano Y; Funae Y
    Arch Biochem Biophys; 1990 Apr; 278(1):168-78. PubMed ID: 2321956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes.
    Dhawan A; Parmar D; Dayal M; Seth PK
    Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
    Murray M; Field SL
    Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cannabidiol-mediated cytochrome P450 inactivation.
    Bornheim LM; Everhart ET; Li J; Correia MA
    Biochem Pharmacol; 1993 Mar; 45(6):1323-31. PubMed ID: 8466552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of GC-MS based cytochrome P450 assay for the investigation of multi-herb interaction.
    Oh HA; Lee H; Kim D; Jung BH
    Anal Biochem; 2017 Feb; 519():71-83. PubMed ID: 28007398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat.
    Kobayashi K; Urashima K; Shimada N; Chiba K
    Drug Metab Dispos; 2003 Jul; 31(7):833-6. PubMed ID: 12814958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.